The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates
暂无分享,去创建一个
L. Buée | R. Bordet | D. Devos | V. Vingtdeux | D. Blum | J. Devedjian | A. Jonneaux | T. Burnouf | F. Knutson | Ouada Nebie | L. Barro | Ming-Li Chou | Ming‐Li Chou | M. Chou
[1] T. Walker,et al. Platelets: the missing link between the blood and brain? , 2019, Progress in Neurobiology.
[2] D. Devos,et al. Past and Future of Neurotrophic Growth Factors Therapies in ALS: From Single Neurotrophic Growth Factor to Stem Cells and Human Platelet Lysates , 2019, Front. Neurol..
[3] Yu-ting Su,et al. A double‐virally‐inactivated (Intercept–solvent/detergent) human platelet lysate for in vitro expansion of human mesenchymal stromal cells , 2019, Transfusion.
[4] R. Henschler,et al. Human platelet lysate current standards and future developments , 2019, Transfusion.
[5] Hsiu-Chen Lin,et al. Four types of human platelet lysate, including one virally inactivated by solvent-detergent, can be used to propagate Wharton jelly mesenchymal stromal cells. , 2019, New biotechnology.
[6] G. Kempermann,et al. Exercise-Induced Activated Platelets Increase Adult Hippocampal Precursor Proliferation and Promote Neuronal Differentiation , 2019, Stem cell reports.
[7] L. Buée,et al. Neuronal AMP-activated protein kinase hyper-activation induces synaptic loss by an autophagy-mediated process , 2019, Cell Death & Disease.
[8] V. Compernolle,et al. Biomolecular Consequences of Platelet Pathogen Inactivation Methods. , 2019, Transfusion medicine reviews.
[9] C. Custódio,et al. Blood Plasma Derivatives for Tissue Engineering and Regenerative Medicine Therapies. , 2018, Tissue engineering. Part B, Reviews.
[10] W. Handke,et al. Ultraviolet C light efficiently inactivates nonenveloped hepatitis A virus and feline calicivirus in platelet concentrates , 2018, Transfusion.
[11] P. Sandgren,et al. Optimized processing for pathogen inactivation of double‐dose buffy‐coat platelet concentrates: maintained in vitro quality over 7‐day storage , 2018, Vox sanguinis.
[12] S. Habtemariam. The brain-derived neurotrophic factor in neuronal plasticity and neuroregeneration: new pharmacological concepts for old and new drugs , 2018, Neural regeneration research.
[13] T. Kreil. Building blocks of the viral safety margins of industrial plasma products , 2018 .
[14] W. Robinson,et al. Men and Women Differ in the Biochemical Composition of Platelet-Rich Plasma , 2018, The American journal of sports medicine.
[15] P. Sandgren. Preserved in vitro metabolic and functional characteristics of double-dose apheresis platelet concentrates photochemically treated with amotosalen and ultraviolet A light. , 2016, Blood transfusion = Trasfusione del sangue.
[16] R. Bordet,et al. The protective effect of human platelet lysate in models of neurodegenerative disease: involvement of the Akt and MEK pathways , 2017, Journal of tissue engineering and regenerative medicine.
[17] D. Devos,et al. Tailor-made purified human platelet lysate concentrated in neurotrophins for treatment of Parkinson's disease. , 2017, Biomaterials.
[18] L. Smirnova,et al. 3D Differentiation of LUHMES Cell Line to Study Recovery and Delayed Neurotoxic Effects , 2017, Current protocols in toxicology.
[19] Q. Lian,et al. Molecular mechanisms of brain-derived neurotrophic factor in neuro-protection: Recent developments , 2017, Brain Research.
[20] J. Polesel,et al. Standardization of platelet releasate products for clinical applications in cell therapy: a mathematical approach , 2017, Journal of Translational Medicine.
[21] A. Bush,et al. Ferroptosis and cell death mechanisms in Parkinson's disease , 2017, Neurochemistry International.
[22] L. Smirnova,et al. Characterization of three human cell line models for high‐throughput neuronal cytotoxicity screening , 2017, Journal of applied toxicology : JAT.
[23] A. Walch,et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. , 2017, Nature chemical biology.
[24] R. Bordet,et al. Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC , 2016, Neurobiology of Disease.
[25] Dirk Strunk,et al. Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation? , 2016, Biomaterials.
[26] G. Scambia,et al. Culture of human cell lines by a pathogen-inactivated human platelet lysate , 2016, Cytotechnology.
[27] T. Jovin,et al. Elevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells , 2015, Cell Death and Disease.
[28] O. Sigurjonsson,et al. Expired and Pathogen-Inactivated Platelet Concentrates Support Differentiation and Immunomodulation of Mesenchymal Stromal Cells in Culture , 2015, Cell transplantation.
[29] G. Duverlie,et al. Inactivation of viruses in platelet and plasma products using a riboflavin‐and‐UV–based photochemical treatment , 2015, Transfusion.
[30] G. Superti-Furga,et al. Human Haploid Cell Genetics Reveals Roles for Lipid Metabolism Genes in Nonapoptotic Cell Death , 2015, ACS chemical biology.
[31] E. Carro,et al. Intranasal PRGF-Endoret enhances neuronal survival and attenuates NF-κB-dependent inflammation process in a mouse model of Parkinson's disease. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[32] N. Lion,et al. The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates. , 2014, Blood reviews.
[33] R. Topolski,et al. Gender and age differences in growth factor concentrations from platelet-rich plasma in adults. , 2014, Military medicine.
[34] C. Humpel,et al. Platelet-derived nerve growth factor supports the survival of cholinergic neurons in organotypic rat brain slices , 2014, Neuroscience Letters.
[35] R. Nieuwland,et al. Single-step isolation of extracellular vesicles by size-exclusion chromatography , 2014, Journal of extracellular vesicles.
[36] M. Gawaz,et al. Platelets in tissue repair: control of apoptosis and interactions with regenerative cells. , 2013, Blood.
[37] J. Galipeau,et al. The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapy. , 2013, Biomaterials.
[38] E. Carro,et al. Intranasal Delivery of Plasma and Platelet Growth Factors Using PRGF-Endoret System Enhances Neurogenesis in a Mouse Model of Alzheimer’s Disease , 2013, PloS one.
[39] O. Sigurjonsson,et al. Platelet Lysates Produced from Expired Platelet Concentrates Support Growth and Osteogenic Differentiation of Mesenchymal Stem Cells , 2013, PloS one.
[40] D. Varon,et al. Platelet lysates stimulate angiogenesis, neurogenesis and neuroprotection after stroke , 2013, Thrombosis and Haemostasis.
[41] T. Burnouf,et al. Human platelet concentrates: a source of solvent/detergent‐treated highly enriched brain‐derived neurotrophic factor , 2012, Transfusion.
[42] Matthew C. Phipps,et al. Delivery of Platelet-Derived Growth Factor as a Chemotactic Factor for Mesenchymal Stem Cells by Bone-Mimetic Electrospun Scaffolds , 2012, PloS one.
[43] M. R. Lamprecht,et al. Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.
[44] Tanja Waldmann,et al. Rapid, complete and large‐scale generation of post‐mitotic neurons from the human LUHMES cell line , 2011, Journal of neurochemistry.
[45] T. Burnouf,et al. A chromatographically purified human TGF‐β1 fraction from virally inactivated platelet lysates , 2011, Vox sanguinis.
[46] M. Ahn,et al. Individual Variation in Growth Factor Concentrations in Platelet-rich Plasma and Its Influence on Human Mesenchymal Stem Cells , 2011, The Korean journal of laboratory medicine.
[47] Lily Lin,et al. Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood SystemTM , 2011, Transfusion Medicine and Hemotherapy.
[48] J. Simon,et al. AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-β Peptide Metabolism* , 2010, The Journal of Biological Chemistry.
[49] D. Strunk,et al. Human Alternatives to Fetal Bovine Serum for the Expansion of Mesenchymal Stromal Cells from Bone Marrow , 2009, Stem cells.
[50] M. Mattson,et al. Mutant Presenilin 1 Increases the Expression and Activity of BACE1* , 2009, Journal of Biological Chemistry.
[51] T. Burnouf. Modern Plasma Fractionation , 2007, Transfusion Medicine Reviews.
[52] Jeppe Falsig,et al. Progressive Degeneration of Human Mesencephalic Neuron-Derived Cells Triggered by Dopamine-Dependent Oxidative Stress Is Dependent on the Mixed-Lineage Kinase Pathway , 2005, The Journal of Neuroscience.
[53] J. Virchow,et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma , 2004, Neurobiology of Aging.
[54] V. Ciaravino,et al. The role of toxicology assessment in transfusion medicine , 2003, Transfusion.
[55] T Burnouf,et al. Reducing the risk of infection from plasma products: specific preventative strategies. , 2000, Blood reviews.
[56] J. Clarke,et al. Medicine , 1907, Bristol medico-chirurgical journal.